No results found for “”
No results found for filter “”
-
Statements & press releases 28.06.24
Strategic Agenda 2024-2029: an opportunity to close the gap with other regions of the world
As we begin a new EU mandate, the focus on competitiveness of the Strategic Agenda gives us an opportunity to restore Europe’s leadership in life sciences....
Read Article -
Statements & press releases 24.06.24
European pharmaceutical industry calls for Competitiveness Strategy and dedicated Office for European...
"Regaining Europe’s position as a world-leader in medical science requires strategic and dedicated focus at EU level" said Nathalie Moll.
Read Article -
EFPIA News 12.06.24
New data from EFPIA reveals multiple factors leading to unequal access to medicines for patients across...
"Whatever the reason, whatever the cause, we stand ready to play our part in reducing the time it takes for patients to access the medicines we discover,...
Read Article -
Statements & press releases 10.06.24
Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement ...
We are leading the transition towards the decarbonisation in the pharmaceutical sector by setting ambitious science-based targets, investing in renewable...
Read Article -
Statements & press releases 05.06.24
Keep health front and centre in the EU elections and beyond – a call from the Patient Think Tank
The Patient Think Tank (PTT) is a forum for dialogue between the European research-based pharmaceutical industry and patient organisations, created and...
Read Article -
Blog articles 05.06.24
Incentives for the development of novel antimicrobials in the revision of the EU general pharmaceutical...
Antimicrobial resistance (AMR) is one of the most urgent global health threats of our time. The statistics are stark and alarming: in Europe alone, AMR...
Read Article -
EFPIA News 04.06.24
Insights from EFPIA's Reliance Webinar
On the 19th of March EFPIA have hosted a joint industry webinar on Reliance, providing a platform for information and discussion on use of EMA assessment...
Read Article -
Blog articles 28.05.24
New data demonstrates the value of regulatory data protection (RDP), and its impact on European competitiveness...
EFPIA believes EU leaders’ focus on competitiveness is positive but more joined-up thinking is urgently needed to achieve open strategic autonomy
Read Article -
Statements & press releases 21.05.24
Pharmaceutical trade associations welcome latest announcement of largest number of regulatory agencies...
The WLA framework is crucial for regulatory convergence and harmonisation.
Read Article -
Blog articles 20.05.24
Lab of the future: when science and technology meet to deliver medicines faster in Europe (Guest blog)...
As science evolves, if you're just keeping up, you're already behind the curve.
Read Article -
Blog articles 16.05.24
Advancing Clinical Trials for European Patients (Guest blog)
Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for clinical research.
Read Article -
Blog articles 15.05.24
Patient involvement in HTA (Guest blog)
Health Technology Assessments: What can we learn from experiences across Europe?
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 12.06.24
New data from EFPIA reveals multiple factors leading to unequal access to medicines for patients across...
"Whatever the reason, whatever the cause, we stand ready to play our part in reducing the time it takes for patients to access the medicines we discover,...
Read Article -
EFPIA News 04.06.24
Insights from EFPIA's Reliance Webinar
On the 19th of March EFPIA have hosted a joint industry webinar on Reliance, providing a platform for information and discussion on use of EMA assessment...
Read Article -
EFPIA News 26.04.24
Journal article - Evolving assessment pathways for precision oncology medicines to improve patient access:...
This study describes challenges in assessing PO and TA medicines, explores possible solutions, and provides actionable recommendations to facilitate an...
Read Article -
EFPIA News 26.04.24
White paper on circular economy
Continued adoption of circular economy principles into the pharmaceutical sector can reduce materials extraction and operational waste, contribute to a...
Read Article -
EFPIA News 28.03.24
NIRO: Navigating Innovation & Research Opportunities
NIRO helps you find available European and international funds for research & innovation.
Read Article -
EFPIA News 13.02.24
European business calls for deepening the EU Single Market and renewing the dynamic of European integration...
Read the joint statement from 26 trade associations.
Read Article -
EFPIA News 06.02.24
Recording Now Available: EJP RD-EFPIA Joint Advanced Webinar on Real-World Data, Machine Learning, and...
...
Read Article -
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
EFPIA News 15.10.23
EFPIA Japan Day 2023
With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo
Read Article -
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article -
EFPIA News 13.07.23
Access to oncology combination therapies in Europe: Today's challenges and solutions
Despite the significant value combination therapies bring to cancer care, there are several challenges to their access in Europe. Without action, some...
Read Article -
EFPIA News 12.06.23
IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days
IHI Call Days: Calls 4 & 5
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 28.06.24
Strategic Agenda 2024-2029: an opportunity to close the gap with other regions of the world
As we begin a new EU mandate, the focus on competitiveness of the Strategic Agenda gives us an opportunity to restore Europe’s leadership in life sciences....
Read Article -
Statements & press releases 24.06.24
European pharmaceutical industry calls for Competitiveness Strategy and dedicated Office for European...
"Regaining Europe’s position as a world-leader in medical science requires strategic and dedicated focus at EU level" said Nathalie Moll.
Read Article -
Statements & press releases 10.06.24
Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement ...
We are leading the transition towards the decarbonisation in the pharmaceutical sector by setting ambitious science-based targets, investing in renewable...
Read Article -
Statements & press releases 05.06.24
Keep health front and centre in the EU elections and beyond – a call from the Patient Think Tank
The Patient Think Tank (PTT) is a forum for dialogue between the European research-based pharmaceutical industry and patient organisations, created and...
Read Article -
Statements & press releases 21.05.24
Pharmaceutical trade associations welcome latest announcement of largest number of regulatory agencies...
The WLA framework is crucial for regulatory convergence and harmonisation.
Read Article -
Statements & press releases 13.05.24
Joint business statement on the EU Proposal on Compulsory Licensing
We believe that, in its current form, this initiative will undermine innovation and competitiveness of European companies, ultimately impeding Europe's...
Read Article -
Statements & press releases 25.04.24
Critical Medicines Alliance: A positive collaboration to enhance medicines supply chain security and...
EFPIA will work within the Alliance to help build resilience through a number of recommendations
Read Article -
Statements & press releases 22.04.24
EFPIA Statement on the use of AI in the medicinal product lifecycle in the context of the AI Act
It is critical that the regulatory frameworks governing the use of AI in research, development and manufacture must be fit-for-purpose, risk-based, non-duplicative,...
Read Article -
Statements & press releases 19.04.24
EFPIA swings behind Council’s call for a European Competitiveness Deal
Time to close the gap
Read Article -
Statements & press releases 17.04.24
Patient Information Leaflets: Putting Patients First
AESGP, EFPIA and Medicines for Europe publish joint recommendations for better patient information leaflets
Read Article -
Statements & press releases 11.04.24
EFPIA response to the European Parliament endorsement of the political agreement on UWWT directive
We support the overall objective of the revision to address water pollution, but we believe that every stakeholder must be part of any solution to enable...
Read Article -
Statements & press releases 10.04.24
EFPIA responds to the European Parliament plenary vote: Despite improvements, the Pharmaceutical Legislation...
Setting out how Europe sees the future of health and life science research and innovation, and patient care in the region.
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 05.06.24
Incentives for the development of novel antimicrobials in the revision of the EU general pharmaceutical...
Antimicrobial resistance (AMR) is one of the most urgent global health threats of our time. The statistics are stark and alarming: in Europe alone, AMR...
Read Article -
Blog articles 28.05.24
New data demonstrates the value of regulatory data protection (RDP), and its impact on European competitiveness...
EFPIA believes EU leaders’ focus on competitiveness is positive but more joined-up thinking is urgently needed to achieve open strategic autonomy
Read Article -
Blog articles 20.05.24
Lab of the future: when science and technology meet to deliver medicines faster in Europe (Guest blog)...
As science evolves, if you're just keeping up, you're already behind the curve.
Read Article -
Blog articles 16.05.24
Advancing Clinical Trials for European Patients (Guest blog)
Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for clinical research.
Read Article -
Blog articles 15.05.24
Patient involvement in HTA (Guest blog)
Health Technology Assessments: What can we learn from experiences across Europe?
Read Article -
Blog articles 06.05.24
More than half of the direct expenditure on diabetes is associated with complications (Guest blog)
In the 2019-2022 period the average annual expenditure on diabetes amounted to 174 million euros.
Read Article -
Blog articles 26.03.24
Innovative Health Initiative: improving health, improving healthcare
From managing obesity to supporting healthier pregnancy, IHI is advancing people’s health and making health systems more efficient
Read Article -
Blog articles 12.03.24
Reintegrating cancer patients into professional and social life (Guest blog)
People with certain cancers are living longer, fuller lives. We must come together to support their return to work
Read Article -
Blog articles 12.03.24
Healthcare innovation moves fast – so should the European regulatory system (Guest blog)
What will the innovations of tomorrow look like and how can they be regulated effectively without delaying access?
Read Article -
Blog articles 06.03.24
How to Unlock the Power of Drug Repurposing? EFPIA perspective
We propose principles to guide policies and legislations that will ensure safety and efficacy of repurposed drugs.
Read Article -
Blog articles 04.03.24
Make or break: The future of Regulatory Data Protection in Europe
When the Prime Minister of Belgium is calling for an Industrial Deal, when the Commission President has tasked former Italian Prime Minister Draghi to...
Read Article -
Blog articles 26.02.24
Imagining a future where rare diseases patients have a better chance at a healthy life
Past legislation has inspired impressive medicines development in Europe and we must continue to drive progress to deliver new, life-changing therapies...
Read Article